Jeffrey Mazer, MD
Critical Care Medicine · Albuquerque, NMNPI 1598982910
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.1%), education and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Intuitive Surgical at 50.4% of the total. Reporting peaked in 2024 at $6,034 and has fallen 87.2% since, to $770 in 2025. Among critical care medicine clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $35.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- AstraZeneca$1K
- GSK$936
- Boehringer Ingelheim$379
- Grifols USA, LLC$348
- Mylan Specialty L.p.$294
- plus $2K from 29 others
What the payments were for
- Travel & lodging$1,70317%
- Food & beverage$5,19052%
- Education$3,07031%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 17 | $5,026 |
| AstraZeneca(2 entities) | 58 | $1,097 |
| GSK | 62 | $936 |
| Boehringer Ingelheim | 24 | $379 |
| Grifols USA, LLC | 19 | $348 |
| Mylan Specialty L.p. | 11 | $294 |
| Regeneron Healthcare Solutions, Inc. | 13 | $285 |
| AbbVie(2 entities) | 9 | $163 |
| Insmed, Inc. | 8 | $150 |
| Siemens Medical Solutions USA, Inc. | 1 | $138 |
| Abiomed | 4 | $133 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $100 |
| Viatris Specialty LLC | 4 | $83 |
| Philips North America LLC | 6 | $80 |
| Genentech USA, Inc. | 5 | $79 |
| Novartis | 3 | $60 |
| Actelion Pharmaceuticals US, Inc. | 2 | $56 |
| Optinose US, Inc. | 3 | $54 |
| Novo Nordisk | 3 | $52 |
| Sunovion Pharmaceuticals Inc. | 4 | $49 |
| Gilead | 2 | $42 |
| Circassia Inc. | 3 | $42 |
| Amgen | 2 | $38 |
| Sanofi | 2 | $38 |
| Merck | 2 | $37 |
| Johnson & Johnson | 1 | $32 |
| Lilly USA, LLC | 1 | $28 |
| Verona Pharma, Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Tactile Systems Technology Inc | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $17 |
| Pfizer | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Boston Scientific | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,686
How this compares
$9,963 in reported general payments places this provider in the 95th percentile of 32 critical care medicine providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 56 | $791,340 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 371 | $314,566 |
| XolairOmalizumab | 72 | $224,945 |
| Spiriva RespimatTiotropium Bromide | 283 | $223,095 |
| Breo ElliptaFluticasone/Vilanterol | 266 | $156,831 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 137 | $126,872 |
| Dupixent PenDupilumab | 31 | $112,866 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 138 | $81,301 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 125 | $77,377 |
| EliquisApixaban | 82 | $58,967 |
| Arnuity ElliptaFluticasone Furoate | 183 | $55,939 |
| NucalaMepolizumab | 12 | $41,610 |
| Incruse ElliptaUmeclidinium Bromide | 79 | $40,972 |
| SymbicortBudesonide/Formoterol Fumarate | 88 | $32,245 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 172 | $32,143 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimOfev, Spiriva Respimat, Stiolto Respimat | $379 | $1,091,811464 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Nucala | $936 | $691,2191,049 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,097 | $166,214242 claims |
| PfizerEliquis | $15 | $58,96782 claims |
| Lilly USA, LLCMounjaro | $28 | $26,11724 claims |
| Johnson & JohnsonXarelto | $32 | $15,23511 claims |
| MerckDulera | $37 | $12,02630 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 32 critical care medicine providers in New Mexico.
Other critical care medicine in Albuquerque
- Staci LogueAlbuquerque$2K
- Denise GonzalesAlbuquerque$1K
- Tyler ShackelfordAlbuquerque$1K
- Lucie GriffinAlbuquerque$746
- Nathan NielsenAlbuquerque$720
- Michel BoivinAlbuquerque$662
- Jennifer VergeerAlbuquerque$609
- Ashley LongAlbuquerque$447
- Akanksha VermaAlbuquerque$356
- Jennifer WichmanAlbuquerque$231
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.